136 related articles for article (PubMed ID: 11018549)
21. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG
Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203
[TBL] [Abstract][Full Text] [Related]
22. Galactosyl conjugated N-succinyl-chitosan-graft-polyethylenimine for targeting gene transfer.
Lu B; Wu DQ; Zheng H; Quan CY; Zhang XZ; Zhuo RX
Mol Biosyst; 2010 Dec; 6(12):2529-38. PubMed ID: 20957247
[TBL] [Abstract][Full Text] [Related]
23. Galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) as a hepatocyte-targeting gene carrier.
Cook SE; Park IK; Kim EM; Jeong HJ; Park TG; Choi YJ; Akaike T; Cho CS
J Control Release; 2005 Jun; 105(1-2):151-63. PubMed ID: 15878633
[TBL] [Abstract][Full Text] [Related]
24. Pegylation effect of chitosan based polyplex on DNA transfection.
Lin WJ; Hsu WY
Carbohydr Polym; 2015 Apr; 120():7-14. PubMed ID: 25662681
[TBL] [Abstract][Full Text] [Related]
25. Targeted gene delivery to hepatocytes with galactosylated amphiphilic cyclodextrins.
McMahon A; O'Neill MJ; Gomez E; Donohue R; Forde D; Darcy R; O'Driscoll CM
J Pharm Pharmacol; 2012 Aug; 64(8):1063-73. PubMed ID: 22775209
[TBL] [Abstract][Full Text] [Related]
26. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation.
Fumoto S; Kawakami S; Ito Y; Shigeta K; Yamashita F; Hashida M
Mol Ther; 2004 Oct; 10(4):719-29. PubMed ID: 15451456
[TBL] [Abstract][Full Text] [Related]
27. Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin.
Zhou N; Zan X; Wang Z; Wu H; Yin D; Liao C; Wan Y
Carbohydr Polym; 2013 Apr; 94(1):420-9. PubMed ID: 23544558
[TBL] [Abstract][Full Text] [Related]
28. Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan.
Kim EM; Jeong HJ; Kim SL; Sohn MH; Nah JW; Bom HS; Park IK; Cho CS
Nucl Med Biol; 2006 May; 33(4):529-34. PubMed ID: 16720245
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo.
Cheng M; Li Q; Wan T; Hong X; Chen H; He B; Cheng Z; Xu H; Ye T; Zha B; Wu J; Zhou R
J Biomed Mater Res B Appl Biomater; 2011 Oct; 99(1):70-80. PubMed ID: 21656667
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution.
Kim EM; Jeong HJ; Park IK; Cho CS; Kim CG; Bom HS
J Nucl Med; 2005 Jan; 46(1):141-5. PubMed ID: 15632044
[TBL] [Abstract][Full Text] [Related]
31. Galactosylated fluorescent labeled micelles as a liver targeting drug carrier.
Wu DQ; Lu B; Chang C; Chen CS; Wang T; Zhang YY; Cheng SX; Jiang XJ; Zhang XZ; Zhuo RX
Biomaterials; 2009 Mar; 30(7):1363-71. PubMed ID: 19100617
[TBL] [Abstract][Full Text] [Related]
32. Galactosylation of chitosan-graft-spermine as a gene carrier for hepatocyte targeting in vitro and in vivo.
Kim JH; Kim YK; Arash MT; Hong SH; Lee JH; Kang BN; Bang YB; Cho CS; Yu DY; Jiang HL; Cho MH
J Nanosci Nanotechnol; 2012 Jul; 12(7):5178-84. PubMed ID: 22966542
[TBL] [Abstract][Full Text] [Related]
33. Alginate/galactosylated chitosan/heparin scaffold as a new synthetic extracellular matrix for hepatocytes.
Seo SJ; Choi YJ; Akaike T; Higuchi A; Cho CS
Tissue Eng; 2006 Jan; 12(1):33-44. PubMed ID: 16499440
[TBL] [Abstract][Full Text] [Related]
34. In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier.
Satoh T; Kakimoto S; Kano H; Nakatani M; Shinkai S; Nagasaki T
Carbohydr Res; 2007 Aug; 342(11):1427-33. PubMed ID: 17548066
[TBL] [Abstract][Full Text] [Related]
35. Novel Galactosylated Poly(ethylene glycol)-Cholesterol for Liposomes as a Drug Carrier for Hepatocyte-Targeting.
Zhang H; Xiao Y; Cui S; Zhou Y; Zeng K; Yan M; Zhao C
J Nanosci Nanotechnol; 2015 Jun; 15(6):4058-69. PubMed ID: 26369013
[TBL] [Abstract][Full Text] [Related]
36. Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes.
Letrou-Bonneval E; Chèvre R; Lambert O; Costet P; André C; Tellier C; Pitard B
J Gene Med; 2008 Nov; 10(11):1198-209. PubMed ID: 18816485
[TBL] [Abstract][Full Text] [Related]
37. Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting.
Morille M; Passirani C; Letrou-Bonneval E; Benoit JP; Pitard B
Int J Pharm; 2009 Sep; 379(2):293-300. PubMed ID: 19505548
[TBL] [Abstract][Full Text] [Related]
38. Functional evaluation of poly-(N-p-vinylbenzyl-O-beta-D-galactopyranosyl-[1-4]-D-gluconamide)(PVLA) as a liver specific carrier.
Watanabe Y; Liu X; Shibuya I; Akaike T
J Biomater Sci Polym Ed; 2000; 11(8):833-48. PubMed ID: 11211095
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
[TBL] [Abstract][Full Text] [Related]
40. Efficient transfection of hepatocytes mediated by mRNA complexed to galactosylated cyclodextrins.
Symens N; Méndez-Ardoy A; Díaz-Moscoso A; Sánchez-Fernández E; Remaut K; Demeester J; Fernández JM; De Smedt SC; Rejman J
Bioconjug Chem; 2012 Jun; 23(6):1276-89. PubMed ID: 22668084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
